Key Market Indicators
Sales of blood and blood forming organs medicine in Norway are expected to reach $351 million by 2026, up from $307 million in 2021. On average, the market has grown 2% year-on-year since 2007. In 2021, Norway was the 17th largest market in the world, behind Portugal, which had sales of $307 million. Germany, Italy and South Korea respectively ranked second, third and fourth. The number of hospital discharges related to anemia in Norway is forecast to reach 4,680 by 2026, up slightly from 4,490 in 2021. Since 2005, the demand has decreased by 0.3% year-on-year. In 2021, the country was ranked 25th worldwide, behind Portugal, which had 4,490 hospital discharges. Germany, the United Kingdom and Poland ranked second, third and fourth respectively.
